Read + Share
Amedeo Smart
Independent Medical Education
Kreger BT, Liang Y, Reilly NM, Spears ME, et al. CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance. Cancer Res 2026;86:438-452.PMID: 41150906
Email
LinkedIn
Privacy Policy